TSPAN5 Antibody

What is TSPAN5 and what cellular functions has it been implicated in?

TSPAN5 is a membrane protein belonging to the tetraspanin superfamily, characterized by four conserved transmembrane regions. It is specifically part of the TSPANC8 subfamily, which also includes TSPAN10, TSPAN14, TSPAN15, TSPAN17, and TSPAN33. TSPAN5 has been implicated in diverse cellular processes including cell activation and proliferation, adhesion and motility, differentiation, and cancer-related processes .

A particularly significant function of TSPAN5 is its direct interaction with ADAM10 (A Disintegrin And Metalloprotease 10). TSPAN5 regulates ADAM10's exit from the endoplasmic reticulum and its subsequent trafficking to the cell surface. This interaction is crucial for Notch signaling pathway regulation, as ADAM10 is required for Notch activation .

TSPAN5 is most abundantly expressed in specific tissues including the brain, lung, kidney, and intestine, suggesting tissue-specific roles in these organs . Research has shown that TSPAN5 can effectively promote Notch signaling, with this effect being inhibitable by certain anti-TSPAN5 monoclonal antibodies .

What are the key characteristics of commercially available TSPAN5 antibodies?

TSPAN5 antibodies are available in both polyclonal and monoclonal formats, each with specific applications and characteristics:

Novel monoclonal antibodies have been developed that provide new insights into TSPAN5 biology. For example, the TS5-2 monoclonal antibody has been validated for detecting endogenous TSPAN5 in both human and mouse cells and does not cross-react with other TSPANC8 tetraspanins .

How does TSPAN5 interact with ADAM10, and what methodological approaches can detect this interaction?

The interaction between TSPAN5 and ADAM10 is of critical importance for both proteins' function and has several noteworthy characteristics:

TSPAN5 directly binds to ADAM10, as demonstrated through co-immunoprecipitation experiments. This interaction is most effectively preserved when using mild detergents such as Brij 97 for cell lysis. In contrast, harsher detergents like RIPA buffer disrupt this interaction, which can be useful for certain experimental designs .

The functional significance of this interaction is multifaceted:

• TSPAN5 regulates ADAM10's exit from the endoplasmic reticulum

• It influences ADAM10's trafficking to the cell surface

• It affects ADAM10's ability to cleave substrates, particularly in Notch signaling

• Different TspanC8 tetraspanins regulate ADAM10's substrate specificity differently

Research using newer monoclonal antibodies has revealed that the majority of TSPAN5 in certain cell lines (U2OS and HCT116) is associated with ADAM10. Interestingly, some anti-TSPAN5 monoclonal antibodies (like TS5-2) do not recognize TSPAN5 when it is associated with ADAM10, providing a valuable tool for measuring the fraction of TSPAN5 not in complex with ADAM10 .

For researchers investigating this interaction, several methodological considerations are important:

• Detergent selection is crucial – mild detergents preserve the interaction while harsh detergents disrupt it

• Antibody selection matters – some antibodies cannot detect TSPAN5-ADAM10 complexes

• The interaction can be modulated by other TspanC8 tetraspanins (transfection with TSPAN15 or TSPAN33 increases the fraction of TSPAN5 not associated with ADAM10)

What are the optimal conditions for Western blotting experiments using TSPAN5 antibodies?

Successful Western blotting for TSPAN5 requires careful optimization of several experimental parameters:

Sample preparation considerations:

• Lysis buffer selection is crucial for detecting different aspects of TSPAN5 biology

• For studying TSPAN5-protein interactions (e.g., with ADAM10), use mild detergents like Brij 97

• For isolating TSPAN5 independently, RIPA buffer effectively dissociates protein interactions

• Jurkat cells serve as a reliable positive control with detectable levels of endogenous TSPAN5

Recommended protocol parameters:

• Protein loading: 20-30 μg of total protein per lane

• SDS-PAGE: 10-12% gels generally work well for TSPAN5 detection

• Transfer: Standard protocols to PVDF or nitrocellulose membranes

• Antibody dilutions:

  • Primary antibody (e.g., 12122-1-AP): 1:2000-1:10000

  • Secondary antibody: Typically 1:5000-1:10000 anti-rabbit or anti-mouse HRP-conjugated

Expected results and interpretation:

• Major band: Look for 30-40 kDa (primary band)

• Secondary bands: May appear at ~22 kDa or ~90 kDa

• These different bands may represent different glycosylated forms or conformations of TSPAN5

Validation controls:

• Positive control: Cells expressing GFP-tagged TSPAN5

• Negative control: TSPAN5-silenced cells (using validated siRNAs)

• Specificity control: Test for cross-reactivity with other TspanC8 tetraspanins

It's important to note that when studying TSPAN5-ADAM10 interactions, some antibodies (like TS5-2) may not recognize TSPAN5 when it's complexed with ADAM10, which can be advantageous for certain experiments but might lead to underestimation of total TSPAN5 levels .

What considerations are important for immunohistochemistry experiments using TSPAN5 antibodies?

For successful immunohistochemistry (IHC) with TSPAN5 antibodies, researchers should address several key methodological aspects:

Tissue preparation and antigen retrieval:

• Standard formalin fixation and paraffin embedding is compatible with TSPAN5 detection

• Recommended antigen retrieval: TE buffer at pH 9.0

• Alternative approach: Citrate buffer at pH 6.0 may also be effective

• Heat-induced epitope retrieval is typically necessary for optimal results

Antibody parameters:

• Primary antibody dilution: 1:500-1:2000 (e.g., for antibody 12122-1-AP)

• Incubation conditions: Typically overnight at 4°C or 1-2 hours at room temperature

• Detection system: Use appropriate HRP-conjugated secondary antibody compatible with the primary antibody's host species

Essential controls:

• Positive tissue control: Human stomach cancer tissue has shown positive staining

• Negative control: Omit primary antibody or use isotype control

• Specificity control: When available, tissues from TSPAN5 knockout mice

Optimization considerations:

• Each new tissue type may require titration of antibody concentration

• Test multiple antibody clones if available, as they may recognize different epitopes

• For tissues with low expression levels, signal amplification methods may be needed

Interpretation guidelines:

• As a membrane protein, TSPAN5 staining should primarily show membrane localization

• Some cytoplasmic staining may be observed, representing intracellular pools

• Compare expression patterns with known high-expression tissues (brain, lung, kidney, intestine)

How can researchers validate the specificity of TSPAN5 antibodies in their experimental systems?

Validating antibody specificity is critical for obtaining reliable results with TSPAN5 antibodies. Researchers should employ multiple complementary approaches:

Genetic validation methods:

• RNA interference: Use validated siRNAs targeting TSPAN5 to confirm signal reduction

  • Example from published research: Two siRNAs reduced TS5-2 mAb staining by 70-80% in flow cytometry

• CRISPR-Cas9 knockout: Generate TSPAN5 knockout cell lines as definitive negative controls

• Overexpression validation: Compare signal in cells with endogenous expression versus overexpressed TSPAN5

  • U2OS cells stably expressing TSPAN5-GFP showed proportional increases in antibody staining

Cross-reactivity testing:

• Test against related proteins: Particularly other TspanC8 family members

• Use chimeric proteins: Test antibodies against chimeras where the Large Extracellular Loop (LEL) has been swapped between tetraspanins

  • Research has shown that antibodies recognized a TSPAN15 chimera with TSPAN5's LEL but not the reverse chimera, confirming LEL-specific binding

Technical validation approaches:

• Western blotting: Confirm single band of expected molecular weight (30-40 kDa)

• Immunoprecipitation followed by mass spectrometry: Confirm identity of precipitated protein

• Epitope mapping: Determine the specific region recognized by the antibody

• Compare multiple antibody clones: Different clones should show similar patterns

Validation across techniques and species:

• Cross-validate results using multiple techniques (Western blot, IHC, flow cytometry)

• Confirm correlation between protein detection and mRNA expression (e.g., via RT-qPCR)

• Test antibody reactivity across relevant species (human, mouse, etc.)

• The high conservation of TSPAN5 across species (human, mouse, and rat TSPAN5 are identical) may help validate antibody performance

Example validation data from published research showed that the TS5-2 mAb recognized endogenous TSPAN5 in both human (HCT116) and mouse (CT26) cell lines, with signal loss in TSPAN5-silenced cells, confirming antibody specificity .

How can researchers distinguish between TSPAN5 and closely related tetraspanins such as TSPAN17?

Distinguishing between TSPAN5 and other closely related tetraspanins, particularly TSPAN17, presents a challenge in research but can be accomplished through several methodological approaches:

Antibody-based differentiation:

• Select highly specific antibodies: While some antibodies recognize both TSPAN5 and TSPAN17 due to their sequence similarity, others are specific to TSPAN5 alone

• Perform rigorous antibody validation: Test antibodies against cells expressing individual tetraspanins, using overexpression systems or knockout controls

• Conduct epitope analysis: Identify antibodies that target non-conserved regions between TSPAN5 and TSPAN17

Molecular techniques for discrimination:

• Western blotting with specific antibodies: Run positive controls for each tetraspanin side-by-side

• RT-qPCR: Design primers targeting non-conserved regions of TSPAN5 and TSPAN17 mRNAs

• RNA-seq analysis: Examine expression patterns of different tetraspanins across cell types

• CRISPR-Cas9 knockout: Create single and double knockout systems to assess functional redundancy

Structural analysis approaches:

• Focus on the Large Extracellular Loop (LEL): This region contains most of the variability between tetraspanins

• Utilize chimeric proteins: Create constructs where specific domains are swapped between TSPAN5 and TSPAN17

• Analyze TspanC8-specific motifs: Research has identified two TspanC8-specific motifs in the LEL of TSPAN5 that are important for ADAM10 interaction

According to published research, investigators have generated antibodies that either:

• Specifically recognize TSPAN5 without cross-reactivity to TSPAN17

• Recognize both TSPAN5 and TSPAN17 (creating "pan" antibodies that can be useful for certain applications)

When absolute discrimination is necessary, combining genetic approaches (e.g., selective knockdown) with specific antibodies provides the most reliable results.

What experimental approaches can be used to study TSPAN5's role in Notch signaling?

To investigate TSPAN5's involvement in Notch signaling, researchers can employ several sophisticated methodological approaches:

Genetic manipulation strategies:

• RNA interference: Use siRNAs targeting TSPAN5 alone or in combination with other TspanC8 tetraspanins

• CRISPR-Cas9 gene editing: Generate TSPAN5 knockout cell lines

• Compensatory experiments: Silence TSPAN5 and TSPAN14 simultaneously, as they can compensate for each other in Notch signaling

Notch signaling assays:

• Ligand-induced Notch activation: Co-culture cells with Notch ligand-expressing cells (e.g., Delta-like or Jagged)

• Reporter gene assays: Use Notch-responsive luciferase reporters (e.g., CSL/RBP-Jκ reporters)

• Western blotting: Detect Notch intracellular domain (NICD) generation

• qRT-PCR: Measure expression of Notch target genes (e.g., HES1, HEY1)

Inhibition approaches:

• Antibody-mediated inhibition: Use antibodies that recognize TSPAN5's LEL

  • Research has shown that two anti-TSPAN5 mAbs inhibited ligand-induced Notch signaling

  • This effect was stronger in cells depleted of TSPAN14, confirming functional compensation

• Domain-specific disruption: Express TSPAN5 with mutations in TspanC8-specific motifs important for ADAM10 interaction

Analysis of TSPAN5-ADAM10 interaction:

• Co-immunoprecipitation: Assess how manipulating TSPAN5 affects its association with ADAM10

• ADAM10 activity assays: Determine how TSPAN5 impacts ADAM10's ability to cleave Notch or other substrates

• Surface biotinylation: Measure how TSPAN5 affects ADAM10 surface expression

Comparative studies:

• Compare TSPAN5's effects with those of other TspanC8 tetraspanins

• Examine how TSPAN5 and TSPAN14 together regulate Notch signaling versus individually

• Contrast with the effects of TSPAN15 and TSPAN33, which inhibit Notch signaling

These approaches provide comprehensive tools for dissecting the specific contributions of TSPAN5 to Notch pathway regulation and its relationship with other TspanC8 family members.

How can researchers investigate the subcellular localization of TSPAN5?

To study the subcellular localization of TSPAN5, researchers can employ several complementary techniques:

Immunofluorescence microscopy approaches:

• Fixed-cell imaging: Use validated TSPAN5 antibodies with appropriate fixation and permeabilization

• Live-cell imaging: Use fluorescently-tagged TSPAN5 constructs (with caution regarding potential artifacts)

• Super-resolution microscopy: Techniques like STORM or PALM to visualize TSPAN5 distribution at nanoscale resolution

Separation of surface and intracellular pools:

• Two-step labeling protocol as described in published research:

  • Label surface TSPAN5 with primary antibody and one color of secondary antibody

  • Permeabilize cells and label total TSPAN5 with the same primary antibody but different color secondary antibody

  • Surface pool appears dual-labeled, while intracellular pool shows only the second color

Co-localization studies:

• Dual immunostaining with markers for:

  • Plasma membrane (e.g., Na⁺/K⁺-ATPase)

  • Endoplasmic reticulum (e.g., calnexin)

  • Golgi apparatus (e.g., GM130)

  • Endosomes (e.g., EEA1, Rab5, Rab7)

  • Lysosomes (e.g., LAMP1)

• Co-localization with ADAM10 to assess their interaction sites

• Co-localization with other tetraspanins (e.g., CD9, CD81)

Quantitative analysis:

• Measure surface/intracellular ratio under different conditions

• Assess changes in localization after stimulation or experimental manipulation

• Compare TSPAN5 distribution with that of other tetraspanins (e.g., CD63, which is primarily intracellular)

Key findings from published research:

• TSPAN5 appears to have a relatively small intracellular pool compared to tetraspanins like CD63

• In flow cytometry of various cell lines, TSPAN5 surface expression was generally low compared to ADAM10 or CD81

• The intracellular signal for TSPAN5 was much lower than that observed for CD63, suggesting different trafficking patterns

This multi-faceted approach enables detailed characterization of TSPAN5's subcellular distribution and trafficking dynamics, providing insights into its functional roles.

What could cause variability in TSPAN5 detection across different experimental conditions?

When investigating variability in TSPAN5 detection, researchers should consider several methodological and biological factors that may influence results:

Antibody-related factors:

• Epitope accessibility: Some antibodies recognize epitopes that can be masked in certain protein complexes

  • Published research shows that the TS5-2 mAb does not recognize TSPAN5 when it's associated with ADAM10

• Antibody specificity: Cross-reactivity with similar tetraspanins (especially TSPAN17) may confound results

• Clone-specific behavior: Different antibody clones may perform differently across applications

Sample preparation considerations:

• Detergent selection: Critical for maintaining or disrupting protein-protein interactions

  • Mild detergents (Brij 97): Preserve tetraspanin complexes

  • Harsh detergents (RIPA): Disrupt interactions but may better expose certain epitopes

• Fixation effects: Overfixation may mask epitopes in immunohistochemistry or immunofluorescence

• Protein denaturation: Native versus denatured conditions affect antibody recognition

Biological variables:

• TSPAN5-ADAM10 association levels: May vary across cell types or experimental conditions

• Post-translational modifications: Glycosylation may affect antibody binding

  • The observed molecular weight of TSPAN5 (30-40 kDa) differs from calculated (30 kDa)

• Expression levels: TSPAN5 shows tissue-specific expression patterns

  • Highest in brain, lung, kidney, and intestine

• Tetraspanin web composition: Interaction with other tetraspanins may affect detection

Optimization strategies:

• Titrate antibody concentration for each application and cell type

• Compare multiple antibody clones side-by-side

• Include appropriate positive and negative controls

• Validate with genetic approaches (siRNA, CRISPR knockout)

• Use orthogonal detection methods to confirm results

Understanding these variables is essential for developing robust TSPAN5 detection protocols and correctly interpreting experimental results across different experimental systems.

How should researchers interpret multiple bands observed in Western blots when using TSPAN5 antibodies?

When multiple bands are observed in Western blots using TSPAN5 antibodies, careful interpretation and validation are required:

Common banding patterns for TSPAN5:

• Primary band: 30-40 kDa (corresponds to the predicted molecular weight of 30 kDa)

• Secondary bands: ~22-27 kDa (thinner band) and ~90 kDa

• Published research shows that the TS5-2 mAb detected "a major ∼27–34-kDa band and a fainter ∼22-kDa thin band"

Interpretation of different molecular weight bands:

• Post-translational modifications:

  • Glycosylation: Tetraspanins are often glycosylated, resulting in higher apparent molecular weight

  • Different glycoforms may appear as multiple bands or smears

• Protein complexes:

  • Incomplete denaturation: Some tetraspanin complexes may be resistant to SDS denaturation

  • Covalent dimers or oligomers: Disulfide-linked complexes may appear as higher molecular weight bands

  • The 90 kDa band might represent TSPAN5 dimers or complexes

• Different conformations:

  • The research suggests multiple bands might represent "different conformations" of TSPAN5

Validation approaches:

• Sample preparation variations:

  • Test different lysis and denaturation conditions

  • Include reducing agents (β-mercaptoethanol, DTT) to disrupt disulfide bonds

  • Treat samples with peptide-N-glycosidase F (PNGase F) to remove N-linked glycans

• Genetic validation:

  • Compare with TSPAN5-silenced cells: All specific bands should be reduced

  • Research shows that both the 27-34 kDa and 22 kDa bands disappeared after silencing TSPAN5

• Multiple antibody comparison:

  • Test different antibody clones against the same samples

  • Consistent patterns across antibodies increase confidence in specificity

Thorough validation ensures accurate interpretation of TSPAN5 Western blot results, with proper consideration of the different molecular forms that may be detected.

What control experiments are essential when studying TSPAN5 across different cell and tissue types?

When investigating TSPAN5 across different cellular and tissue contexts, several control experiments are essential for result validation:

Antibody specificity controls:

• Positive expression control: Include cells/tissues known to express TSPAN5 (e.g., brain, lung, kidney, intestine)

• Negative expression control: Use cells with TSPAN5 genetically silenced or knocked out

• Cross-reactivity control: Test antibody against related tetraspanins, especially TSPAN17

• Isotype control: Use matched isotype antibody to assess non-specific binding

Genetic manipulation controls:

• siRNA validation: Use multiple independent siRNAs targeting TSPAN5

  • Published research shows two validated siRNAs reduced TS5-2 staining by 70-80%

• Rescue experiments: Restore TSPAN5 expression in knockout/knockdown cells

• Overexpression control: Compare endogenous versus overexpressed TSPAN5 detection

Application-specific controls:

For Western blotting:

• Loading control: Confirm equal protein loading with housekeeping proteins

• Molecular weight ladder: Accurately determine apparent molecular weight

• Positive control lysate: Include a reference sample with known TSPAN5 expression (e.g., Jurkat cells)

For immunohistochemistry/immunofluorescence:

• Tissue-specific positive controls: Include tissues known to express TSPAN5

• Secondary antibody-only control: Assess background staining

• Blocking peptide control: Confirm antibody specificity by pre-incubation with immunizing peptide

Interaction analysis controls:

• Detergent controls: Compare mild (Brij 97) versus harsh (RIPA) detergents

• Antibody competition: Some antibodies may compete with ADAM10 binding

• Co-immunoprecipitation specificity: Include unrelated proteins as negative controls

Functional assay controls:

• Pathway specificity: Include controls for related signaling pathways

• Compensation controls: Consider functional redundancy with other TspanC8 tetraspanins

  • TSPAN5 and TSPAN14 can compensate for each other in Notch signaling

These comprehensive controls ensure robust and reproducible results when studying TSPAN5 across different experimental contexts.